Acknowledgment of Financial Commercial Support No financial commercial support was received for this educational activity.
Acknowledgment of In-Kind Commercial Support No in-kind commercial support was received for this educational activity.
Satisfactory Completion Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. You must attend the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement In support of improving patient care, this activity has been planned and implemented by Amedco LLC and National Hispanic Medical Association. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians Amedco LLC designates this live activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Learner Notification Objectives - After Attending This Program You Should Be Able To 1. Understand the potential impacts of COVID-19 variants on vulnerable communities of color with lower vaccination rates 2. Learn about different types of variant treatment and the importance of getting vaccinated 3. Learn about communication strategies to increase vaccination rates of vulnerable communities, focused on the Latino population
Disclosure of Conflict of Interest The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)
All individuals in a position to control the content of CE are listed in the program book. If their name is not listed below, they disclosed that they had no financial relationships with a commercial interest.